中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2010年
23期
36-38
,共3页
刘丽艳%常焕显%王以翠%庄建光
劉麗豔%常煥顯%王以翠%莊建光
류려염%상환현%왕이취%장건광
瑞舒伐他汀%急性脑梗死%神经功能
瑞舒伐他汀%急性腦梗死%神經功能
서서벌타정%급성뇌경사%신경공능
Rosuvastatin%Acute cerebral infarction%Neurological function
目的 观察瑞舒伐他汀对急性脑梗死患者疗效及脑梗死体积变化的影响.方法 将100例急性脑梗死患者随机分为观察组52例和对照组48例,对照组患者入院后均给予常规治疗方法,观察组在对照组治疗的基础上加服瑞舒伐他汀20 mg/d.两组均连续治疗30 d.检测两组患者神经功能缺损程度评分和脑梗死灶体积.结果 治疗后观察组梗死灶体积显著低于治疗前及对照组(P均<0.05);观察组患者神经功能缺损程度评分低于对照组(P<0.01),Barthel指数高于对照组(P<0.01);观察组总有效率显著高于对照组(P<0.05).瑞舒伐他汀不良反应轻微.结论 瑞舒伐他汀能加速脑梗死患者神经功能的恢复,可缩小脑梗死体积,有保护神经的作用.
目的 觀察瑞舒伐他汀對急性腦梗死患者療效及腦梗死體積變化的影響.方法 將100例急性腦梗死患者隨機分為觀察組52例和對照組48例,對照組患者入院後均給予常規治療方法,觀察組在對照組治療的基礎上加服瑞舒伐他汀20 mg/d.兩組均連續治療30 d.檢測兩組患者神經功能缺損程度評分和腦梗死竈體積.結果 治療後觀察組梗死竈體積顯著低于治療前及對照組(P均<0.05);觀察組患者神經功能缺損程度評分低于對照組(P<0.01),Barthel指數高于對照組(P<0.01);觀察組總有效率顯著高于對照組(P<0.05).瑞舒伐他汀不良反應輕微.結論 瑞舒伐他汀能加速腦梗死患者神經功能的恢複,可縮小腦梗死體積,有保護神經的作用.
목적 관찰서서벌타정대급성뇌경사환자료효급뇌경사체적변화적영향.방법 장100례급성뇌경사환자수궤분위관찰조52례화대조조48례,대조조환자입원후균급여상규치료방법,관찰조재대조조치료적기출상가복서서벌타정20 mg/d.량조균련속치료30 d.검측량조환자신경공능결손정도평분화뇌경사조체적.결과 치료후관찰조경사조체적현저저우치료전급대조조(P균<0.05);관찰조환자신경공능결손정도평분저우대조조(P<0.01),Barthel지수고우대조조(P<0.01);관찰조총유효솔현저고우대조조(P<0.05).서서벌타정불량반응경미.결론 서서벌타정능가속뇌경사환자신경공능적회복,가축소뇌경사체적,유보호신경적작용.
Objective To observe the effect of rosuvastatin on efficacy and volume changes of cerebral infarction in patients with acute cerebral infarction. Methods One hundred patients with acute cerebral infarction were randomly divided into observe group (52 cases) and control group (48 cases). The control group were given conventional treatment after admission, the observe group were given rosuvastatin(20 mg/day) treatment on the basis of conventional treatment.Both groups were treated for 30 days. Neurological deficit scores and infarct volumes of two groups were recorded. Results After treatment, the infarct volume of the observe group was significantly lower than before treatment and the control group(P all<0.05),the neurologic impairment score of the observe group was lower than the control group(P<0.01),the Barthel index of the observe group was higher than the control group(P<0.01),the total effective rate of the observe group was significantly higher than the control group (P<0.05). The side effects of rosuvast were minor. Conclusions Rosuvastatin can accelerate the recovery of neurological function in patients with cerebral infarction, can reduce infarct size and has the effect of nerve protection.